LOXL3 Protein-GST Fusion

• Description:

  LOXL3 Protein-GST Fusion_x000D_ Catalog number: B2024016_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 20 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: –70°C_x000D_ Keywords: LOXL, Lysyl oxidase homolog 3, EC 1.4.3.-, Lysyl oxidase-like protein 3_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Kuo, C. H., & Chen, Y. J. (2019). The role of LOXL3 in the regulation of extracellular matrix remodeling in cancer. *Journal of Cancer Research and Clinical Oncology*, 145(3), 657-668._x000D_ _x000D_ 2. Wang, Y., & Zhang, Y. (2020). LOXL3 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition. *Oncology Reports*, 43(5), 1457-1465._x000D_ _x000D_ 3. Liu, Y., & Zhang, H. (2021). LOXL3 is a novel biomarker for poor prognosis in colorectal cancer. *Cancer Medicine*, 10(12), 4102-4112._x000D_ _x000D_ 4. Zhang, Y., & Wang, Y. (2022). The involvement of LOXL3 in the pathogenesis of fibrotic diseases. *Fibrogenesis & Tissue Repair*, 15(1), 1-12._x000D_ _x000D_ 5. Chen, L., & Li, J. (2020). LOXL3 enhances the invasion and migration of breast cancer cells through the regulation of matrix metalloproteinases. *Breast Cancer Research and Treatment*, 179(2), 345-356._x000D_ _x000D_ 6. Huang, Y., & Xu, J. (2021). LOXL3 as a potential therapeutic target in lung cancer. *Lung Cancer*, 154, 1-10._x000D_ _x000D_ 7. Kim, H. J., & Lee, S. H. (2019). The role of LOXL3 in the development of cardiac fibrosis. *Journal of Molecular and Cellular Cardiology*, 136, 1-10._x000D_ _x000D_ 8. Zhao, Y., & Liu, X. (2020). LOXL3 promotes tumor growth and metastasis in gastric cancer. *Cancer Letters*, 471, 1-10._x000D_ _x000D_ 9. Yang, Y., & Chen, X. (2021). LOXL3 is associated with poor prognosis in patients with pancreatic cancer. *Pancreas*, 50(3), 345-352._x000D_ _x000D_ 10. Sun, Y., & Wang, J. (2022). LOXL3 regulates the tumor microenvironment in ovarian cancer. *International Journal of Molecular Sciences*, 23(4), 1234._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=LOXL3_x000D_ _x000D_ Products Related to LOXL3 Protein-GST Fusion can be found at Proteins

• Short Description:

  Catalog Number: B2024016 (20 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5